Dr Damien Kee is a Consultant Medical Oncologista doctor who specialises in the study, diagnosis and treatment of cancer specialising in melanomaa type of cancer that develops from melanocytes, which are the cells that produce pigment generally in the skin (but can develop in other areas of the body) and skin cancers, rare cancers and genomics. He is a Fellow of the Royal Australian College of Physicians (Medical Oncologythe study, diagnosis and treatment of cancer) and obtained a Doctor of Medical Science investigating melanoma biology and imagingtests that create detailed images of areas inside the body (University of Melbourne). Damien also leads the melanoma and skin cancera disease where abnormal cells split without control and spread to other nearby body tissue and/or organs services at the Austin Hospital; and is a clinician-scientist at the Walter Eliza Hall Institute of Medical Research, developing national rare cancer research infrastructure such as the WEHI Stafford Fox Rare Cancer Program and Australian Rare Cancer Portal.
Dr Kee is a Governance Committee Member of Melanoma Research Victoria; Deputy Chair of the COSA Rare Cancers Group; and a member of the VCCC Personalised Cancer Care Steering Group. He has been a principal investigator on pivotal studies of targeted and immune therapies for melanoma and rare cancers; clinical studies genomic sequencing; and clinical and research platforms to improve rare cancer outcomes. Damien’s publications include original research in the journals: The New England Journal of Medicine, Journal of Clinical Oncology, Cancer Cell, The Lancet Oncology, Annals of Oncology, Clinical Cancer Research, and JAMA Oncology.
Location
Austin Hospital, 145 Studley Road, Heidelberg VIC, Australia
